Claudio Bonifati
10PUBLICATIONS
65CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Feb 19, 2026
Psychological Well-Being of Patients with Moderate-to-Severe Plaque Psoriasis Treated with Tildrakizumab: 28-Week Interim Results from a Multicenter Observational Study in Italy Using the DASS-21 Questionnaire, the BLUE Study.Emanuele Trovato, Claudio Bonifati, Simone Ribero
|Feb 27, 2024
Efficacy and safety of tildrakizumab in elderly patients: real-world multicenter study (ESTER - study).Diego Orsini, Giacomo Caldarola, Annunziata Dattola
|Jun 16, 2022
Real-world outcomes in patients with moderate-to-severe plaque psoriasis treated with guselkumab for up to 1 year.Marco Galluzzo, Marina Talamonti, Nicoletta Bernardini
|Apr 06, 2022
Risankizumab for the treatment of moderate-to-severe psoriasis: A multicenter, retrospective, 1 year real-life study.Giacomo Caldarola, Arianna Zangrilli, Nicoletta Bernardini
|Jul 19, 2021
Predictive factors of lack of response to adalimumab among bio-naive patients suffering from moderate-to severe psoriasis: analysis of a multicenter data collection in Italy.Arianna Zangrilli, Giacomo Caldarola, Nicoletta Bernardini
|Nov 25, 2020
Effectiveness of anti-interleukin 23 biologic drugs in psoriasis patients who failed anti-interleukin 17 regimens. A real-life experience.Claudio Bonifati, Aldo Morrone, Antonio Cristaudo
Pageof 2
Frequent Collaborators
4 joint publications
Antonio Richetta
3 joint publications
Ketty Peris
3 joint publications
Marco Galluzzo
3 joint publications
Giacomo Caldarola
3 joint publications
Gaia Moretta
2 joint publications
Luca Bianchi
2 joint publications
Nicoletta Bernardini
2 joint publications
Arianna Zangrilli
2 joint publications
Mauro Bavetta
2 joint publications
Gianluca Pagnanelli
